ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Testosterone replacement does not increase heart attacks and strokes in young men.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 20506" data-attributes="member: 3"><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26124832#" target="_blank"></a></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26124832#" target="_blank">[ATTACH]1479[/ATTACH]</a></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26124832#" target="_blank"></a></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26124832#" target="_blank"></a></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/26124832#" target="_blank">Int J Endocrinol.</a> 2015;2015:970750. doi: 10.1155/2015/970750. Epub 2015 Jun 1.</p><p></p><p></p><p><strong>Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone.</strong></p><p></p><p>Tan RS</p><p><strong>Abstract</strong></p><p></p><p></p><p>This study was conducted to examine the association between testosterone therapy and new myocardial infarction (MI) and stroke events in a series of patients treated at Low T Centers across the United States, consisting of mainly young (mean age = 46), otherwise, healthy men. Electronic medical records were queried between the years 2009 and 2014 to identify patients diagnosed with hypogonadism, MI, and stroke, as indicated by ICD-9 codes. The incidence of MI and stroke events was compared to community-based registries. 39,936 patients recruited from 40 Low T Centers across the United States were treated and 19,968 met eligibility criteria for receiving testosterone treatment. The incidence rate ratio (IRR) for MI in testosterone- (T-) treated versus nontreated patients was 0.14 (C.I. = 0.08 to 0.18, P < 0.0001) whereas the IRR for stroke for T-treated versus nontreated patients was 0.11 (C.I. = 0.02 to 0.13, P < 0.0001). There was no evidence of worsening preexisting MI or stroke in patients treated with testosterone. The experience in Low T Centers shows that, in an injectable testosterone patient registry, testosterone is generally safe for younger men who do not have significant risk factors. Of patients that developed MI with testosterone, there was no association with testosterone or hematocrit levels.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 20506, member: 3"] [URL="http://www.ncbi.nlm.nih.gov/pubmed/26124832#"] [ATTACH=CONFIG]1479[/ATTACH] Int J Endocrinol.[/URL] 2015;2015:970750. doi: 10.1155/2015/970750. Epub 2015 Jun 1. [B]Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone.[/B] Tan RS [B]Abstract[/B] This study was conducted to examine the association between testosterone therapy and new myocardial infarction (MI) and stroke events in a series of patients treated at Low T Centers across the United States, consisting of mainly young (mean age = 46), otherwise, healthy men. Electronic medical records were queried between the years 2009 and 2014 to identify patients diagnosed with hypogonadism, MI, and stroke, as indicated by ICD-9 codes. The incidence of MI and stroke events was compared to community-based registries. 39,936 patients recruited from 40 Low T Centers across the United States were treated and 19,968 met eligibility criteria for receiving testosterone treatment. The incidence rate ratio (IRR) for MI in testosterone- (T-) treated versus nontreated patients was 0.14 (C.I. = 0.08 to 0.18, P < 0.0001) whereas the IRR for stroke for T-treated versus nontreated patients was 0.11 (C.I. = 0.02 to 0.13, P < 0.0001). There was no evidence of worsening preexisting MI or stroke in patients treated with testosterone. The experience in Low T Centers shows that, in an injectable testosterone patient registry, testosterone is generally safe for younger men who do not have significant risk factors. Of patients that developed MI with testosterone, there was no association with testosterone or hematocrit levels. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Testosterone replacement does not increase heart attacks and strokes in young men.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top